Tirzepatide 10mg/3mL

What is Tirzepatide?

Tirzepatide is a groundbreaking dual-hormone receptor agonist that simultaneously targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. As one of the most talked-about compounds in metabolic research today, it represents a significant evolution from single-receptor GLP-1 agonists, offering researchers a powerful tool for studying dual-incretin pathways.

The dual-action mechanism of Tirzepatide has made it one of the most studied compounds in obesity and metabolic research, with clinical data showing remarkable outcomes that have captured the attention of the scientific community worldwide.

Mechanism of Action

Tirzepatide is being studied for its potential to influence:

• GLP-1 receptor activation — supports satiety signaling, slows gastric emptying, and promotes insulin secretion
• GIP receptor activation — enhances insulin response and may improve fat metabolism and energy storage
• Dual-incretin synergy — combined receptor engagement may amplify metabolic effects beyond single-agonist approaches
• Appetite and food intake regulation — central and peripheral pathways for satiety modulation

Areas of Research

Current clinical and preclinical studies are evaluating Tirzepatide's potential role in:

• Body weight regulation and obesity management
• Glucose metabolism and type 2 diabetes research
• Cardiovascular metabolic health
• Dual-incretin pathway pharmacology

Research Use Only

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical use, diagnosis, cure, mitigation, treatment, or prevention of any disease. This product has not been evaluated by the U.S. Food and Drug Administration (FDA). Purchasers are responsible for compliance with all applicable laws and regulations regarding the use and handling of research materials.